BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 16282639)

  • 1. Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes.
    Masson D; Pais de Barros JP; Zak Z; Gautier T; Le Guern N; Assem M; Chisholm JW; Paterniti JR; Lagrost L
    J Lipid Res; 2006 Feb; 47(2):356-65. PubMed ID: 16282639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
    Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
    J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity.
    Guyard-Dangremont V; Lagrost L; Gambert P
    J Lipid Res; 1994 Jun; 35(6):982-92. PubMed ID: 8077854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein CI overexpression is not a relevant strategy to block cholesteryl ester transfer protein (CETP) activity in CETP transgenic mice.
    Gautier T; Masson D; Jong MC; Pais de Barros JP; Duverneuil L; Le Guern N; Deckert V; Dumont L; Bataille A; Zak Z; Jiang XC; Havekes LM; Lagrost L
    Biochem J; 2005 Jan; 385(Pt 1):189-95. PubMed ID: 15339254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of cholesteryl ester transfer protein inhibitor from plasma of baboons (Papio sp.).
    Kushwaha RS; Hasan SQ; McGill HC; Getz GS; Dunham RG; Kanda P
    J Lipid Res; 1993 Aug; 34(8):1285-97. PubMed ID: 8409763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of lipid-free apolipoprotein A-I from high density lipoproteins.
    Liang HQ; Rye KA; Barter PJ
    J Lipid Res; 1994 Jul; 35(7):1187-99. PubMed ID: 7964180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
    Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
    Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
    Melchior GW; Castle CK; Murray RW; Blake WL; Dinh DM; Marotti KR
    J Biol Chem; 1994 Mar; 269(11):8044-51. PubMed ID: 8132527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue-specific CETP expression in mice: impact on plasma lipoprotein metabolism.
    Zhou H; Li Z; Hojjati MR; Jang D; Beyer TP; Cao G; Tall AR; Jiang XC
    J Lipid Res; 2006 Sep; 47(9):2011-9. PubMed ID: 16751623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
    Zhou H; Li Z; Silver DL; Jiang XC
    Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin.
    Bisgaier CL; Siebenkas MV; Brown ML; Inazu A; Koizumi J; Mabuchi H; Tall AR
    J Lipid Res; 1991 Jan; 32(1):21-33. PubMed ID: 2010691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential interaction of the human cholesteryl ester transfer protein with plasma high density lipoproteins (HDLs) from humans, control mice, and transgenic mice to human HDL apolipoproteins. Lack of lipid transfer inhibitory activity in transgenic mice expressing human apoA-I.
    Masson D; Duverger N; Emmanuel F; Lagrost L
    J Biol Chem; 1997 Sep; 272(39):24287-93. PubMed ID: 9305883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of CETP inhibitory peptide and lipoprotein substrates in cholesteryl ester transfer assay: relationship between association properties and inhibitory activities.
    Cho KH; Lee JY; Choi MS; Bok SH; Park YB
    Lipids; 2002 Jul; 37(7):641-6. PubMed ID: 12216834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats.
    Zak Z; Gautier T; Dumont L; Masson D; Deckert V; Duverneuil L; Pais De Barros JP; Le Guern N; Schneider M; Moulin P; Bataillard A; Lagrost L
    Atherosclerosis; 2005 Feb; 178(2):279-86. PubMed ID: 15694935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular determinants of plasma cholesteryl ester transfer protein binding to high density lipoproteins.
    Bruce C; Davidson WS; Kussie P; Lund-Katz S; Phillips MC; Ghosh R; Tall AR
    J Biol Chem; 1995 May; 270(19):11532-42. PubMed ID: 7744792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein lipase enhances the cholesteryl ester transfer protein-mediated transfer of cholesteryl esters from high density lipoproteins to very low density lipoproteins.
    Tall AR; Sammett D; Vita GM; Deckelbaum R; Olivecrona T
    J Biol Chem; 1984 Aug; 259(15):9587-94. PubMed ID: 6746661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipid transfer protein on plasma lipids, apolipoproteins and metabolism of high-density lipoprotein cholesteryl ester in the rat.
    Groener JE; van Gent T; van Tol A
    Biochim Biophys Acta; 1989 Mar; 1002(1):93-100. PubMed ID: 2493808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
    Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.